Intended for Canadian Healthcare Professionals Only

Clinical Materials & Resources



Application Protocols Poster
Application Protocols Pocket Guide
Collagenase SANTYL® Ointment Brochure
Case Study Brochure
Cycle of Inflammation Poster


Occasional slight transient erythema has been noted in surrounding tissue when applied outside the wound. One case of systemic hypersensitivity has been reported after 1 year of treatment with collagenase and cortisone.
Use of Collagenase SANTYL® Ointment should be terminated when debridement is complete and granulation tissue is well established.
See complete prescribing information for more details.

Mechanism of Action Video

moa video
About SANTYL® Ointment

Active Micro-Debridement
Active Micro-Debridement
learn more link
Application Protocol for
SANTYL® Ointment

learn more link
SANTYL® is a registered trademark of Healthpoint Biotherapeutics. Healthpoint Biotherapeutics and design is a registered trademark of Healthpoint Biotherapeutics.
© 2010 Healthpoint Canada ULC. All rights reserved.
The information on this site is intended for customers, patients, and healthcare professionals in Canada only. All information, including the Prescribing Information for Collagenase SANTYL® Ointment, abides by the laws, regulatory requirements, and medical practices for Canada only and may not be appropriate for use outside of Canada.